News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Wednesday, December 6, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point

      From Medscape Neurology

      Coverage from the

      9th Joint European Committee for Treatment and Research in Multiple Sclerosis-Americas Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS-ACTRIMS) 2023

      October 11 - 13, 2023; Milan, Italy

      October 11 - 13, 2023 Milan, Italy
      • ECTRIMS-ACTRIMS 2023 Ocrelizumab Benefit Confirmed in Older Patients With MS The relapse benefit of ocrelizumab in multiple sclerosis is confirmed for the first time in patients 60 and older starting therapy, say researchers in findings they hope will inform choices.
        Medscape Medical News, October 12, 2023
      • ECTRIMS-ACTRIMS 2023 AI Tool Reveals MS Drug Interactions, Offers Safer Options Clinicians prescribing a drug for patients with multiple sclerosis who are on multiple treatments may in future use AI to identify potential interactions and suggest safer options, new data suggest.
        Medscape Medical News, October 12, 2023

      Conference News

      Medscape Neurology© WebMD, LLC

      Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

      Popular News From ECTRIMS 2022

      • Can MS Be Stopped Early in its Tracks? Can MS Be Stopped Early in its Tracks? The first randomized trial of a disease-modifying therapy in radiological isolated syndrome, the earliest pre-clinical phase of MS, suggests dimethyl fumarate reduced the risk of a first clinical event by 80%.
        Medscape Medical News, Oct 31, 2022
      • 'Tantalizing' New Data for Ibudilast in Multiple Sclerosis 'Tantalizing' New Data for Ibudilast in Multiple Sclerosis New data from SPRINT-MS show that the drug has beneficial effects on slowly evolving lesions in people with multiple sclerosis, perhaps by abrogating chronic active lesions.
        Medscape Medical News, Nov 04, 2022
      • MRI a Viable Alternative to Lumbar Puncture for MS Diagnosis? MRI a Viable Alternative to Lumbar Puncture for MS Diagnosis? The central vein sign is an emerging neuroimaging biomarker for multiple sclerosis that may reduce the need for lumbar puncture to detect oligoclonal bands in CSF, a pilot study shows.
        Medscape Medical News, Oct 28, 2022

      Related Resources

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.